Endoscopic treatment of Barrett's oesophagus

References

• Sampliner RE. Practice guidelines: updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 2002;97:1888–95.
   PubMed Web of Science ®Google Scholar
• Neumann CS, Cooper BT. 24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett’s oesophagus. Gut 1994; 35:1352–55.
   PubMedGoogle Scholar
• Singh P, Taylor RH, Colin-Jones DG. Oesophageal motor dysfunction and acid exposure in reflux oesophagi are more severe if Barrett’s metaplasia is present. Am J Gastroenterol 1994;89:349–56.
   Google Scholar
• Falk GW. Barrett’s oesophagus. Gastroenterology 2002; 122: 1569–91.
   PubMed Web of Science ®Google Scholar
• Romero Y, Cameron AJ, Locke GR, Schaid DJ, Slezak JM, Branch CD, et al. Familial aggregation of gastroesophageal reflux in patients with Barrett’s oesophagus and oesophageal adenocarcinoma. Gastroenterology 1997;113:1149–56.
   Google Scholar
• Chak A, Lee T, Kinnard MF, Brock W, Foulx A, Willis J, et al. Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarnima in Caucasian adults. Gut 2002;51:323–8.
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Lomboy CT. Barrett’s oesophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241–5.
   PubMed Web of Science ®Google Scholar
• Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the oesophagus and oesophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116:277–85.
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Crosbey MA, Bozynski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett’s oesophagus? Gastroenterology 2000;119:333–8.
   PubMed Web of Science ®Google Scholar
• Levine DS, Reid BJ. Endoscopic biopsy technique for acquiring larger mucosal samples. Gastrointest Endosc 1991;37:332–7.
   PubMed Web of Science ®Google Scholar
• Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate highgrade dysplasia from early adenocarcinoma in Barrett’s oesophagus. Gastroenterology 1993;105:40–50.
   PubMed Web of Science ®Google Scholar
• Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett’s oesophagus and its implications for disease progression. Am J Gastroenterol 2000;95:3383–7.
   PubMed Web of Science ®Google Scholar
• Spechler SJ. Barrett’s oesophagus. N Engl J Med 2002;346:836–42.
   PubMed Web of Science ®Google Scholar
• Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett’s oesophagus with high-grade dysplasia. Gastrointest Endosc 1999;49:170–6.
   PubMed Web of Science ®Google Scholar
• Romagnoli R, Collard JM, Gutschow C, Yamusah N, Salizzoni M. Outcomes of dysplasia arising in Barrett’s oesophagus a dynamic view. J Am Coll Surg 2003;197:365–71.
   Google Scholar
• Reid BJ, Blount PL, Feng Z, Lavine DS. Optimising endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol 2000;95:3089–96.
   PubMed Web of Science ®Google Scholar
• Ormsby AH, Petras RE, Henricks WH, Rice TW, Rybic LA, Goldblum JR. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002;51:671–6.
   PubMed Web of Science ®Google Scholar
• Reid BJ, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, Levine BS, et al. Predictors of progression in Barrett’s oesophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 2001;96:2839–48.
   PubMed Web of Science ®Google Scholar
• Teodori L, Gohde W, Persiani M, Ferrario F, Tirindelli Danesi D, Scarpignato C, et al. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett’s oesophagus: thirteen-year follow-up study on a cohort of patients. Cytometry 1998;34:257–63.
   PubMedGoogle Scholar
• Shaheen N, Ransohoff DF. Gastroesophageal reflux. Barrett’s oesophagus and oesophageal cancer; scientific review. JAMA 2002;287:1972–81.
   Google Scholar
• Craanen ME, Blok P, Meijer GA, Meeuwissen SGM. Surveillance in Barrett’s oesophagus: a critical reappraisal. Scan J Gastroenterol 2002;37 Suppl 236:4–8.
   Google Scholar
• Spechler SJ. Clincal practice; Barrett’s oesophagus. N Engl J Med 2002;346:836–42.
   PubMed Web of Science ®Google Scholar
• Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett’s oesophagus with high-grade dysplasia: an indication for oesophagectomy? Ann Thorac Surg 1992;54:199–204.
   PubMed Web of Science ®Google Scholar
• Rice TW, Zuccaro GJ, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR. Oesophageal carcinoma: depth of tumour invasion is predictive of regional lymph node status. Ann Thorac Surg 1998;65:787–92.
   PubMed Web of Science ®Google Scholar
• Scheiman JM, Wang KK. EMR for early stage oesophageal cancer: setting the stage for improved patient outcomes [editorial]. Gastrointest Endosc 2003;58:244–6.
   PubMedGoogle Scholar
• Fennerty MB. Endoscopic ablation of Barrett’s related neoplasia: what is the evidence supporting its use? [editorial]. Gastrointest Endosc 2003;58:246–9.
   PubMedGoogle Scholar
• Ginsberg GG. Endoluminal therapy for Barrett’s with high-grade dysplasia and early oesophageal adenocarcinoma [editorial]. Clin Gastroenterol Hepatol 2003;1:241–5.
   PubMedGoogle Scholar
• Ell C, May A, Gossner L, Pech O, Gunter E, Mayer A, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s oesophagus. Gastroenterology 2000; 118: 670–7.
   PubMed Web of Science ®Google Scholar
• Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s oesophagus. Gastrointest Endosc 2000;52:328–32.
   PubMed Web of Science ®Google Scholar
• Buttar NS, Wang KK, Lutze LS, Krisnadath KK, Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for oesophageal neoplasia within Barrett’s oesophagus. Gastrointest Endosc 2001;54:682–8.
   Google Scholar
• Ahmad NA, Kochman ML, Long WB, Furth EE, Ginsberg GG. Efficacy, safety and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc 2002; 55: 390–6.
   Google Scholar
• May A, Gossner L, Pech O, Fritz A, Günter E, Mayer G, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14:1085–91.
   Google Scholar
• May A, Gossner L, Behrens A, Kohnen R, Vieth M, Stolte M, et al. A prospective randomised trial of two different endoscopic resection techniques for early cancers of the oesophagus. Gastrointest Endosc 2003;58:167–75.
   PubMed Web of Science ®Google Scholar
• Seewald S, Akaraviputh T, Sieta U, Brand F, Groth S, Mendoze G, et al. Circumferential endoscopic mucosal resection and complete removal of Barrett’s epithelium; a new approach in the management of Barrett’s oesophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003;57:854–9.
   PubMed Web of Science ®Google Scholar
• Fleischer D. Endoscopic mucosal resection: (not) made in the U.S.A. (so commonly). A dissection of the definition, techniques, use, and controversies [editorial]. Gastrointest Endosc 2000;52: 440–4.
   Google Scholar
• Rosenberg N. Submucosal saline wheal as a safety factor in fulguration of rectal and sigmoid polyps. Arch Surg 1955;70: 120–3.
   Google Scholar
• Rembacken BJ, Gotoda T, Fuji T, Axon ATR. Endoscopic mucosal resection. Endoscopy 2001;33:709–18.
   PubMedGoogle Scholar
• Tani M, Sakai P, Koudo H. Endoscopic mucosal resection of superficial cancer in the stomach using the cap technique. Endoscopy 2003;35:348–55.
   Google Scholar
• Soetikno RM, Gotoda T, Nakanishi Y, Soekendra N. Technological review: endoscopic mucosal resection. Gastrointest Endosc 2003;57:567–79.
   PubMed Web of Science ®Google Scholar
• Montes CG, Brandalise NA, Deliza R, Novais de Magelhaes AF, Ferraz JGP. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett’s oesophagus. Gastrointest Endosc 1999;50:173–7.
   Google Scholar
• Michopoulos S, Tsibouris P, Bouzakis H, Sotiropoulou M, Kralios N. Complete regression of Barrett’s oesophagus with heat probe thermocoagulation: mid-term results. Gastrointest Endosc 1999;50:165–72.
   Google Scholar
• Schulz H, Miehlke S, Antos D, Schentke KU, Vieth M, Stolte M, et al. Ablation of Barrett’s epithelium by endoscopic argon plasma-coagulation in combination with high-dose omeprazole. Gastrointest Endosc 2000;51:659–63.
   PubMed Web of Science ®Google Scholar
• Pereira-Lima JC, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowiski CB, et al. High power setting argon plasma coagulation for the eradication of Barrett’s oesophagus. Am J Gastroenterol 2000;95:1661–8.
   Google Scholar
• van Laethem J-L, Jagodzinski R, Peny MO, Cremer M, Deviere J. Argon plasma coagulation in the treatment of Barrett’s high-grade dysplasia and in situ carcinoma. Endoscopy 2001;33:257–61.
   Google Scholar
• Sampliner RE, Faigel D, Fennerty B, Lieberman D, Ippoliti A, Lewin K, et al. Effective and safe endoscopic reversal of nondysplastic Barrett’s oesophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 2001;53:554–8.
   PubMed Web of Science ®Google Scholar
• Basu KK, Pick B, Bale R, West KP, de Caesteker JS. Efficacy and one-year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium. Gut 2002;51:776–80.
   Google Scholar
• Kahaleh M, van Laethem J-L, Nagy N, Cremer M, Deviere J. Long-term follow-up and factors predictive of recurrence in Barrett’s oesophagus treated by argon/plasma coagulation and acid suppression. Endoscopy 2002;34:950–5.
   Google Scholar
• Attwood SEA, Lewis CJ, Caplin S, Hemming K, Armstrong G. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett’s oesophagus. Clin Gastroenterol Hepatol 2003;1:258–63.
   Google Scholar
• Weston AP, Sharma P. Neodymium: yttrium-aluminium garnet contact laser ablation of Barrett’s high-grade dysplasia and early adenocarcinoom. Am J Gastroenterol 2002;97:2998–3006.
   PubMedGoogle Scholar
• Fisher RS, Bromer MQ, Thomas RM, Cohen S, Krevsky B, Horwitz B, et al. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation. Am J Gastroenterol 2003;98:1945–51.
   PubMedGoogle Scholar
• Bowers SP, Mattar SG, Waring PJ, Galloway K, Nasir A, Pascal R, et al. KTP laser ablation of Barrett’s oesophagus after antireflux surgery results in long-term loss of intestinal metaplasia. Surg Endosc 2003;17:49–54.
   PubMedGoogle Scholar
• Barr H, Shepherd NA, Dix A, Roberts DJ, Tan WL, Krusner N. Eradication of high-grade dysplasia in columnar-lined (Barrett’s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996;348:584–5.
   PubMed Web of Science ®Google Scholar
• Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s oesophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448–55.
   PubMed Web of Science ®Google Scholar
• Ackroyd R, Brown NJ, Davis MF, Stephenson TJ, Marcus SL, Stoddard CJ. Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut 2000;47:612–7.
   PubMed Web of Science ®Google Scholar
• Panjehpour M, Overholt BF, Haydek JM, Lee SG. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s oesophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 2000;95:2177–84.
   PubMed Web of Science ®Google Scholar
• Ortner MA, Zumbusch K, Liebertruth J, Ebert B, Fleige B, Dietel M, et al. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett’s oesophagus? A pilot study. Endoscopy 2002;34:611–6.
   PubMedGoogle Scholar
• Ackroyd R, Kelty CJ, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MWR. Eradication of dysplastic Barrett’s oesophagus using photodynamic therapy: long-term follow-up. Endoscopy 2003;35:496–501.
   PubMed Web of Science ®Google Scholar
• Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett’s oesophagus with dysplasia and or early stage carcinoma: long-term results. Gastrointest Endosc 2003; 58: 183–8.
   Google Scholar
• Pacifico RJ, Wang KK, Wongkeesong L-M, Buttar NS, Lutzke LS. Combined endoscopic mucosal resection and photodynamic therapy versus oesophagectomy for management of early adenocarcinoma in Barrett’s oesophagus. Clin Gastroenterol Hepatol 2003;1:252–7.
   Google Scholar
• Hinnen P, de Rooij FW, van Velthuysen ML, Edixhoven A, van Hillegersberg R, Tilanus RW. Biochemical basis of 5-aminolae- vulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer 1998;78:679–82.
   PubMedGoogle Scholar
• Nishioka NS. Drug, light and oxygen: a dynamic combination in the clinic. Gastroenterology 1998;114:604–6.
   PubMedGoogle Scholar
• Wang KK. Photodynamic therapy made simple. Clinic Persp Gastroenterol 2001;4:90–100.
   Google Scholar
• Fennerty MB. Barrett’s-related oesophageal cancer: had the final hurdle been cleared, now paving the way for human chemopre-vention trails? Gastroenterology 2003;122:1172–5.
   Google Scholar